NAVLE Integumentary

Canine Anal Sac Disease Study Guide

Anal sac disease encompasses a spectrum of disorders affecting the paired anal sacs located at approximately the 4 and 8 o'clock positions relative to the anus.

Overview and Clinical Importance

Anal sac disease encompasses a spectrum of disorders affecting the paired anal sacs located at approximately the 4 and 8 o'clock positions relative to the anus. These conditions represent one of the most common presenting complaints in small animal practice, with an estimated incidence of 12 to 16 percent in dogs and less than 1 percent in cats. The clinical spectrum ranges from simple impaction to life-threatening neoplasia, making accurate diagnosis and appropriate treatment critical for NAVLE success.

The anal sacs are invaginations of the cutaneous zone of the anal canal, positioned between the internal and external anal sphincter muscles. Each sac is lined by stratified squamous epithelium and contains both apocrine and sebaceous glands that produce a pungent secretion used for territorial marking and individual identification.

Risk Factor Clinical Significance
Small Breed Dogs Cocker Spaniels, Cavalier King Charles Spaniels, Chihuahuas, Pomeranians, and other toy breeds are significantly overrepresented. Smaller anal sac ducts and proportionally larger sacs increase impaction risk.
Obesity Excess perianal fat interferes with normal sphincter muscle function and reduces the effectiveness of anal sac compression during defecation.
Chronic Diarrhea Soft or liquid stool fails to provide adequate mechanical pressure to compress anal sacs during defecation, leading to incomplete emptying.
Low-Fiber Diet Inadequate dietary fiber results in smaller, softer stools that do not adequately stimulate anal sac emptying.
Allergic Skin Disease Atopic dermatitis and food allergies can cause perianal inflammation, pruritus, and secondary anal sac duct stenosis from chronic inflammation and self-trauma.
Anatomic Abnormalities Congenital or acquired duct stenosis, abnormal duct positioning, or anal sac diverticula can prevent normal emptying.
Generalized Seborrhea Primary seborrhea or other causes of glandular hypersecretion increase the volume and viscosity of anal sac secretions.

Anatomy and Physiology

Anatomic Structure

The anal sacs are paired structures positioned bilaterally at the 4 and 8 o'clock positions (or 5 and 7 o'clock) around the anus, located between the internal and external anal sphincter muscles. Each sac communicates with the cutaneous zone of the anus via a single duct that opens just lateral to the anal opening.

Size: Normal anal sacs range from the size of a small pea to a kidney bean, approximately 0.5 to 4 cm in diameter in dogs, with variation based on breed size. Smaller breeds tend to have proportionally larger anal sacs relative to body size.

Glandular Composition: The wall of each anal sac contains both apocrine and sebaceous glands embedded in fibrous connective tissue. In dogs, apocrine glands are concentrated in the fundus of the sac, while sebaceous glands line the ductal area. The apocrine glands produce the majority of the secretion volume.

Normal Physiology

Secretion: The anal sacs produce a foul-smelling, oily secretion that varies in color from yellow-brown to gray-brown and in consistency from watery to thick and pasty. This secretion contains a complex mixture of lipids, proteins, and volatile compounds that provide a unique chemical signature for each individual dog.

Normal Emptying: During normal defecation, the external anal sphincter muscle contracts and compresses the anal sacs, forcing secretion through the ducts onto the surface of the stool. This occurs near the end of defecation. Anal sac emptying can also occur spontaneously during times of fear, stress, or excitement.

NAVLE TipFor NAVLE questions, remember that normal anal sac emptying requires firm, well-formed stools to create adequate pressure during defecation. Chronic diarrhea or soft stools are significant risk factors for impaction because they fail to provide sufficient mechanical compression of the sacs.
Condition Medical Treatment Additional Management
Impaction Manual Expression: Gentle external digital pressure to evacuate contents. If contents too dry, infuse softening agent (docusate sodium or saline) and re-express after 5-10 minutes. Dietary Modification: Add fiber supplement (psyllium or pumpkin). Weight reduction if obese. Address underlying GI disease. Routine expression every 4-8 weeks if recurrent.
Sacculitis Anal Sac Flushing: Flush with sterile saline or dilute chlorhexidine until fluid runs clear. Topical Infusion: Instill antibiotic-steroid ointment (e.g., gentamicin-betamethasone, neomycin-polymyxin-hydrocortisone) directly into sac. Systemic Antibiotics: Cephalexin 22-30 mg/kg PO q12h or amoxicillin-clavulanate 13.75 mg/kg PO q12h for 10-14 days. Pain Management: NSAIDs (carprofen 2.2 mg/kg PO q12h) or other analgesics. Warm Compresses: Apply to perianal area 10-15 minutes 3-4 times daily. Recheck in 7-10 days; may require repeat infusion.
Abscess Intact Abscess: Sedation or anesthesia often required. Surgical lancing if fluctuant. Copious flushing with sterile saline. Systemic broad-spectrum antibiotics. Ruptured Abscess: Debride devitalized tissue. Flush tract thoroughly. Place drain if significant tissue defect. Culture and sensitivity testing recommended. E-collar: Prevent self-trauma during healing. Analgesics: NSAIDs plus consider tramadol 2-4 mg/kg PO q8-12h. Stool softeners may help reduce straining. Consider anal sacculectomy if chronic recurrence.
Recurrent Disease Anal Sacculectomy: Surgical removal of anal sacs indicated after 3 or more episodes despite medical management. Open or closed technique available. Complications: Fecal incontinence (10-15 percent), wound dehiscence, anal stricture, infection. Address Underlying Causes: Treat allergic skin disease. Optimize diet and weight. Consider food trial if food allergy suspected. Manage GI disease. Perform anal sacculectomy after controlling active infection for best outcome.

Anal Sac Impaction

Definition and Pathophysiology

Anal sac impaction is the overfilling and distention of the anal sacs with retained secretion that becomes abnormally thick and difficult to express. This is the most common form of anal sac disease, accounting for approximately 56 percent of all non-neoplastic anal sac conditions.

Impaction develops when the anal sacs fail to empty adequately during defecation. As secretions accumulate, they become progressively thicker and more paste-like, eventually becoming inspissated (dried and compacted). The sac becomes distended, causing discomfort and potentially predisposing to secondary infection.

Risk Factors

Clinical Signs

The hallmark clinical signs of anal sac impaction reflect discomfort and the dog's attempts to relieve pressure:

  • Scooting (dragging the rear end along the ground): The most recognizable sign, occurring as the dog attempts to express the sacs or relieve discomfort
  • Excessive licking or biting at the perianal area: Often focused at the base of the tail or directly around the anus
  • Tail chasing: Particularly in young dogs, may indicate anal sac discomfort
  • Reluctance to sit or defecate: Due to pain from distended sacs
  • Strong fishy odor: Caused by partial or spontaneous expression of retained secretions
  • Visible wetness or staining around the anus: From involuntary leakage of anal sac contents
High-YieldWhile scooting is the most recognized sign, it is not pathognomonic for anal sac disease. The differential diagnosis for scooting includes perianal fistulas, rectal foreign bodies, tapeworm segments, perianal tumors, and other causes of perianal pruritus. Always perform a thorough digital rectal examination.

Diagnosis

Digital rectal examination is the gold standard for diagnosis. With the gloved index finger inserted into the rectum, the examiner can palpate each anal sac externally by placing the thumb lateral to the anus. Impacted sacs feel firm, distended, and non-compressible.

Manual expression confirms impaction. In normal sacs, a small amount of liquid secretion is easily expressed with gentle pressure. In impacted sacs, the material is thick, paste-like, and may be expressed only as a ribbon with significant pressure. The secretion may be tan, brown, or gray and have a characteristic foul odor.

Diagnostic Test Findings and Clinical Utility
Digital Rectal Examination Firm, enlarged, non-expressible anal sac that cannot be flushed. May be unilateral or bilateral. Palpation of sublumbar lymph nodes (when accessible).
Fine Needle Aspirate (FNA) Cytology shows round to oval bare nuclei, basilar epithelial cells with scant pale cytoplasm, minimal pleomorphism despite malignant behavior. Suggestive but not definitive.
Biopsy (Incisional or Excisional) Definitive diagnosis. Histopathology confirms apocrine gland origin. Evaluate surgical margins, mitotic index, and degree of differentiation.
Serum Chemistry Total calcium, ionized calcium (more accurate), phosphorus, BUN, creatinine, PTH (should be low-normal or suppressed), PTHrP (elevated but not routinely measured).
Abdominal Ultrasound Evaluate sublumbar (medial iliac and hypogastric) lymph nodes for metastasis. Lymph nodes greater than 1 cm or rounded shape are suspicious. Assess liver, spleen, and kidneys.
Thoracic Radiographs (3-view) Screen for pulmonary metastases. Less common site than lymph nodes but important for staging and prognosis.
Computed Tomography (CT) Superior to ultrasound for detecting sublumbar lymphadenomegaly. Better visualization of pelvic anatomy and local invasion. Helpful for surgical planning.

Anal Sacculitis (Inflammation and Infection)

Definition and Pathophysiology

Anal sacculitis refers to inflammation of the anal sac lining, typically progressing from simple impaction. When the inspissated secretions are not removed, bacterial overgrowth occurs within the sac, leading to infection and inflammation. Sacculitis represents approximately 26 percent of non-neoplastic anal sac disease cases.

The pathophysiology involves obstruction of the anal sac duct, retention of secretions, bacterial proliferation, and inflammatory response. Common bacterial isolates include Escherichia coli, Staphylococcus species, Streptococcus species, and Clostridium species. If left untreated, sacculitis can progress to abscess formation.

Clinical Signs

Dogs with anal sacculitis demonstrate more pronounced signs of pain and discomfort compared to simple impaction:

  • Severe pain when sitting or defecating
  • Intense licking, biting, or chewing at the perianal region
  • Swelling, erythema, and heat around one or both anal sacs
  • Discoloration of the perianal skin (reddened or purple-tinged)
  • Foul-smelling, purulent discharge that may be blood-tinged
  • Behavioral changes including irritability and reluctance to be touched around the tail base
  • Dyschezia (painful or difficult defecation) with straining

Diagnosis

Diagnosis is confirmed through digital rectal examination and cytologic evaluation of expressed material:

Physical Examination: The affected anal sac feels firm, hot, and painful to palpation. The dog may vocalize or show signs of distress during examination. Sedation may be required for thorough evaluation.

Cytology: Microscopic examination of expressed material reveals large numbers of polymorphonuclear leukocytes (neutrophils), bacteria (often both intracellular and extracellular), and inflammatory debris. The presence of degenerate neutrophils indicates active infection.

Bacterial Culture: In cases of recurrent or severe sacculitis, aerobic and anaerobic bacterial culture with antimicrobial sensitivity testing guides appropriate antibiotic selection. This is particularly important given increasing antimicrobial resistance.

Treatment Modality Details and Considerations
Hypercalcemia Management (Pre-operative) Aggressive IV Fluid Therapy: 0.9 percent NaCl at 2-4 times maintenance to promote calciuresis. Furosemide: 2-4 mg/kg IV q8-12h after rehydration (caution with volume depletion and renal function). Bisphosphonates: Pamidronate 1-2 mg/kg IV over 2 hours or zoledronate 0.1-0.25 mg/kg IV. Inhibits osteoclastic bone resorption. Glucocorticoids: Prednisone 1-2 mg/kg PO q12-24h ONLY after lymphoma ruled out. Decreases intestinal calcium absorption.
Surgical Excision (Anal Sacculectomy) Primary Treatment: Complete excision of affected anal sac with wide margins when feasible. May require resection of adjacent tissues. Sublumbar Lymphadenectomy: Removal of enlarged medial iliac lymph nodes via ventral midline celiotomy. Improves survival time even if metastatic. Complications: Fecal incontinence (temporary or permanent, 10-15 percent), anal stricture, wound dehiscence, hypocalcemia (transient, post-operative).
Radiation Therapy Indications: Incomplete surgical margins, large tumors, local recurrence, metastatic sublumbar lymph nodes. Protocols: Definitive radiation (daily fractions over 3-4 weeks) or palliative (coarse fractionation, fewer treatments). Can be used pre-operatively to shrink tumors, intra-operatively, or post-operatively. Side Effects: Acute radiation dermatitis, proctitis, diarrhea. Late effects may include fibrosis or stricture.
Chemotherapy Carboplatin: 300 mg/m² IV q21 days for 4-6 treatments. Most commonly used adjuvant agent. Mitoxantrone: 5 mg/m² IV q21 days for 4-6 treatments. Alternative to carboplatin. Melphalan: Oral alkylating agent; some reports of efficacy. Toceranib (Palladia): Tyrosine kinase inhibitor, 2.5-2.8 mg/kg PO every other day. Clinical benefit in 69 percent of dogs. Used for metastatic disease or as adjuvant therapy.

Anal Sac Abscess

Definition and Pathophysiology

Anal sac abscess represents the progression of untreated or inadequately treated sacculitis. The infected sac becomes severely inflamed, and a localized collection of purulent material (pus) accumulates within the sac. As pressure builds, the wall of the anal sac becomes compromised and may eventually rupture through the skin adjacent to the anus, creating a draining fistulous tract.

Anal sac abscesses account for approximately 18 percent of non-neoplastic anal sac disease. The condition is extremely painful and requires immediate veterinary intervention.

Clinical Presentation

Pre-Rupture: Severe perianal swelling, firm fluctuant mass lateral to the anus, marked erythema, extreme pain especially during defecation, fever may be present, patient may be lethargic or anorexic

Post-Rupture: Visible draining tract near the anus, purulent or serosanguineous discharge, immediate pain relief after rupture followed by continued discomfort, foul odor, visible tissue defect or ulceration

NAVLE TipAnal sac abscesses must be differentiated from perianal fistulas (anal furunculosis). Perianal fistulas are chronic, progressive lesions most commonly seen in German Shepherds and involve the tissues around the anus, not the anal sacs themselves. Fistulas typically present with multiple draining tracts, whereas anal sac abscesses usually present with a single drainage point at the site of rupture.

Treatment of Non-Neoplastic Anal Sac Disease

Anal Sac Adenocarcinoma (Apocrine Gland Adenocarcinoma)

Overview and Epidemiology

Apocrine gland anal sac adenocarcinoma (AGASACA) is a malignant tumor arising from the apocrine glands lining the wall of the anal sac. While relatively uncommon, comprising approximately 2 percent of all canine skin tumors, it represents 17 percent of all perianal malignancies and is one of the most common causes of paraneoplastic hypercalcemia in dogs.

Signalment: Mean age at diagnosis is 10 to 11 years. Historical reports suggested female dogs were overrepresented, but more recent large studies show equal distribution between spayed females and castrated males. Interestingly, intact male dogs may have a protective effect from testosterone.

Breed Predispositions: Cocker Spaniels, English Springer Spaniels, Cavalier King Charles Spaniels, German Shepherds, Dachshunds, and Alaskan Malamutes are overrepresented.

Clinical Signs

Clinical presentation varies depending on tumor size, location, and presence of metastases:

Local Signs: Perianal swelling or mass (may be unilateral or bilateral), firm, non-expressible anal sac on rectal examination, constipation or obstipation from mass effect, tenesmus or dyschezia, ribbon-shaped stools, scooting or perianal licking (less common than with impaction)

Systemic Signs: Polyuria and polydipsia (PU/PD) from hypercalcemia (25 to 53 percent of cases), weight loss, lethargy, inappetence, signs of renal insufficiency (azotemia) secondary to hypercalcemia, lymphadenopathy (sublumbar nodes often enlarged)

Approximately 30 percent of dogs are asymptomatic, and the tumor is discovered incidentally during routine physical examination or when investigating hypercalcemia.

High-YieldAny older dog presenting with hypercalcemia and PU/PD should be evaluated for anal sac adenocarcinoma with a thorough digital rectal examination and measurement of ionized calcium. The tumor may be small and easily missed without careful palpation.

Paraneoplastic Hypercalcemia

Hypercalcemia occurs in 25 to 53 percent of dogs with anal sac adenocarcinoma, making this tumor one of the most common causes of humoral hypercalcemia of malignancy (HHM) in dogs.

Mechanism: The tumor produces parathyroid hormone-related peptide (PTHrP), which mimics the action of parathyroid hormone (PTH) by binding to PTH receptors in bone and kidney. This results in increased osteoclastic bone resorption, increased renal tubular reabsorption of calcium, and increased renal phosphate excretion.

Laboratory Findings: Elevated total and ionized calcium, hypophosphatemia (71 percent of cases), normal or low parathyroid hormone (PTH) levels, azotemia (if chronic hypercalcemia causes renal damage), isosthenuria (dilute urine due to nephrogenic diabetes insipidus)

Clinical Consequence: The hypercalcemia itself can cause significant morbidity including polyuria and polydipsia, vomiting, constipation, muscle weakness, cardiac arrhythmias, and acute or chronic kidney injury. Hypercalcemia typically resolves within 24 to 48 hours after complete tumor excision, followed by transient hypocalcemia as suppressed parathyroid glands recover.

NAVLE TipRemember the mnemonic for differential diagnosis of hypercalcemia: HARDIONS - Hypoadrenocorticism, Anal sac adenocarcinoma, Renal disease, Vitamin D toxicosis, Idiopathic (in cats), Osteolytic lesions, Neoplasia (lymphoma, multiple myeloma), Spurious (lab error).

Diagnosis and Staging

Metastatic Pattern: Anal sac adenocarcinoma has a high metastatic rate. Approximately 50 to 79 percent of dogs have sublumbar lymph node metastases at time of diagnosis. Distant metastases to lungs, liver, spleen, and vertebrae occur but are less common at initial presentation.

Treatment

Multimodal Approach: Treatment typically combines surgery, radiation therapy, and chemotherapy for optimal outcomes.

Prognosis

Prognosis is highly variable and depends on multiple factors:

Favorable Prognostic Factors: Tumor size less than 2.5 cm or less than 10.7 cm², no metastases at diagnosis, complete surgical excision with clean margins, normocalcemic at presentation, aggressive multimodal treatment

Negative Prognostic Factors: Tumor size greater than 2.5 cm, presence of lymph node metastases, distant metastases (lungs), hypercalcemia, incomplete surgical margins

Survival Times: Overall median survival time ranges from 12 to 18 months with multimodal therapy. Dogs treated with surgery alone: 6-12 months median survival. Dogs with surgery plus radiation and chemotherapy: 18-36 months possible. Dogs with tumors less than 2.5 cm and no metastases can survive over 3 years. Dogs with hypercalcemia have shorter survival (median 8-9 months).

Local recurrence occurs in up to 45 percent of cases, emphasizing the importance of aggressive local control with surgery and radiation.

Practice NAVLE Questions

Test your knowledge with 10,000+ exam-style questions, detailed explanations, and timed exams.

Start Your Free Trial →